September 1, 2009 โ Sanofi-aventis said Sunday the investigational anti-Xa intravenous anti-coagulant otamixaban ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
September 1, 2009 โ AstraZeneca last week announced results from the phase III head to head trial, PLATO (A Study ...
August 13, 2009 โ Abbott today announced the expansion of the company's XIENCE V USA post-approval study designed ...
August 13, 2009 โ The pharmaceutical and healthcare research firm Decision Resources found Merck/Schering-Plough ...
August 10, 2009 โ Health Care Service Corp. (HCSC), which operates the Blue Cross and Blue Shield plans in ...
August 6, 2009 โ Palatin Technologies Inc. said this week it received a notice of allowance from the U.S. Patent ...
August 6, 2009 โ Merck & Co. Schering-Plough Corp. and the companies' cholesterol joint venture, Merck/Schering ...
August 5, 2009 โ Nile Therapeutics Inc. said this week it dosed its first patient in a phase 2 clinical study of ...
August 4, 2009 โ Watson Pharmaceuticals Inc. said this week it received FDA approval on its abbreviated new drug ...
August 3, 2009 โ Kowa Research Institute (KRI) and Kowa Pharmaceuticals America Inc. (KPA) said today the FDA has ...
July 31, 2009 โ United Therapeutics Corp. said yesterday the FDA approved TYVASO (treprostinil) Inhalation ...
July 28, 2009 โ Sanofi-aventis said today MULTAQ (dronedarone) 400 mg tablets are now available in pharmacies in ...
July 22, 2009 โ The FDA this week approved Tekturna HCT (aliskiren and hydrochlorothiazide) tablets as initial ...
July 13, 2009 โ Daiichi Sankyo Inc. and Eli Lilly and Company said Friday the FDA approved Effient (prasugrel) ...
July 10, 2009 โ Merck & Co. Inc. and Portola Pharmaceuticals Inc. this week signed an exclusive global ...
September 01, 2009